Personalis, Inc.
General ticker "PSNL" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $453.8M (TTM average)
Personalis, Inc. follows the US Stock Market performance with the rate: 59.1%.
Estimated limits based on current volatility of 4.2%: low 8.31$, high 9.04$
Factors to consider:
- Total employees count: 229 (+1.8%) as of 2024
- US accounted for 96.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: High operating expenses, Lack of profitability, Labor/talent shortage/retention, Strategic risks and growth management, Regulatory and compliance
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [5.04$, 10.74$]
- 2026-12-31 to 2027-12-31 estimated range: [3.96$, 8.84$]
Financial Metrics affecting the PSNL estimates:
- Negative: with PPE of -9.0 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -10.27 <= 0.01
- Positive: Shareholder equity ratio, % of 78.16 > 64.29
- Positive: Interest expense per share per price, % of 0.03 <= 0.73
- Positive: -4.43 < Investing cash flow per share per price, % of -3.09
Short-term PSNL quotes
Long-term PSNL plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $73.48MM | $84.61MM | $0.00MM |
| Operating Expenses | $183.42MM | $152.88MM | $88.06MM |
| Operating Income | $-109.94MM | $-68.27MM | $-88.06MM |
| Non-Operating Income | $1.72MM | $-13.00MM | $6.81MM |
| Interest Expense | $0.11MM | $0.02MM | $0.20MM |
| R&D Expense | $64.78MM | $48.91MM | $50.26MM |
| Income(Loss) | $-108.21MM | $-81.27MM | $-81.25MM |
| Taxes | $0.08MM | $0.02MM | $0.02MM |
| Profit(Loss)* | $-108.30MM | $-81.28MM | $-81.27MM |
| Stockholders Equity | $129.44MM | $202.96MM | $261.19MM |
| Inventory | $5.66MM | $3.98MM | $6.14MM |
| Assets | $225.10MM | $270.27MM | $334.16MM |
| Operating Cash Flow | $-56.26MM | $-45.15MM | $-74.95MM |
| Capital expenditure | $10.91MM | $1.60MM | $4.50MM |
| Investing Cash Flow | $13.10MM | $-35.07MM | $-22.57MM |
| Financing Cash Flow | $11.03MM | $114.67MM | $130.34MM |
| Earnings Per Share** | $-2.25 | $-1.37 | $-0.91 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.